Javier Chaparro-Riggers, Ph.D.Vice President, BioMedicine Design at PfizerSpeaker
Profile
Javier joined Pfizer in 2007 and is leading the BioTherapeutic Discovery department within Biomedicine Design. He is responsible for leading biotherapeutic discovery work, including lead generation and optimization, biophysical characterization, and non-GLP biotherapeutic production. During his tenure at Pfizer he worked on conventional/bispecific/trispecific antibodies, antibody-cytokine fusions, antibody drug conjugates, CAR T cells, oncolytic viruses and mRNA therapies. Javier is interested in understanding the underlying biology of drug design and delivery and engineering solutions for challenges associated with developing the next generation of biotherapeutics.
Agenda Sessions
Co-Chairs' Remarks: Engineering Considerations for Candidate Selection and Developability
, 1:00pmView SessionOptimizing Antibodies for Efficacy
, 1:15pmView Session